AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 34.21 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $21.702 million which beat the analyst consensus estimate of $20.167 million by 7.61 percent. This is a 17.83 percent increase over sales of $18.418 million the same period last year.